Blood test may predict immunotherapy success in head and neck cancer
NCT ID NCT07396259
First seen Feb 10, 2026 · Last updated May 15, 2026 · Updated 18 times
Summary
This study is looking for a better way to predict if immunotherapy will help people with head and neck cancer. Currently, doctors use a tissue sample, but that can't be easily repeated. Researchers will test a simple blood test that looks at cancer cells and immune markers to see if it can predict treatment response. The goal is to make immunotherapy more personalized and effective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNOTHERAPY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Linkou Chang Gung Memorial Hospital
RECRUITINGTaoyuan, City, 333, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.